Drapalin Pharmaceuticals
About Drapalin Pharmaceuticals
Drapalin Pharmaceuticals is a Munich-based cannabis company focused on the import and distribution of pharmaceutical-grade medical cannabis in Germany. The company has established partnerships with international cultivators and operates GDP-compliant distribution infrastructure. Drapalin was one of the early entrants in the German medical cannabis market following the 2017 legalization of medical cannabis.
Key Facts
- 1One of the first medical cannabis distributors in Germany post-2017 legalization
- 2Headquartered in Munich with nationwide pharmacy supply
- 3Maintains partnerships with producers in Canada, Portugal, and other markets
Frequently Asked Questions
When did Drapalin enter the cannabis market?
Drapalin was founded in 2017, the same year Germany legalized medical cannabis prescriptions, making it one of the pioneering distributors in the German market.
What sets Drapalin apart from other distributors?
Drapalin was among the first companies to establish import and distribution infrastructure for medical cannabis in Germany, giving it established relationships with international producers and deep knowledge of the regulatory framework.
More Cannabis Companies in Munich
Cannabis Laws
Products
- Imported medical cannabis flowers
- Cannabis extract products
- Dronabinol preparations
Specialties
Company Details
- Type
- Distributor
- Location
- Munich, Germany
- Founded
- 2017
- Publicly Traded
- No